Last updated: February 24, 2026
What is the scope and focus of patent MX2016002246?
Patent MX2016002246 pertains to a pharmaceutical invention filed in Mexico. The patent was granted on July 29, 2016, and assigned to Mexico-based inventors or applicants, focusing on a new composition, process, or use related to a pharmaceutical compound or formulation.
The patent claims cover the composition of matter, method of production, and methods of use, depending on the patent's specific claims. Although the detailed claims are not provided explicitly here, typical scope for such patents includes:
- Active ingredients: The chemical or biological compound(s) involved.
- Formulation: Specific formulations such as tablets, capsules, or injectables.
- Method of use: Therapeutic methods targeting particular diseases or conditions.
- Manufacturing process: Technical procedures for synthesizing or processing the active ingredient.
Key Points
- Likely covers a novel pharmaceutical compound or combination.
- May include formulations with enhanced stability, bioavailability, or targeted delivery.
- Might specify a novel therapeutic method or treatment indication.
What are the detailed claims?
Without the full text, typical claims for a patent of this nature generally involve:
- Independent Claims: Covering the core compound or composition, possibly with specific structural features or purity levels.
- Dependent Claims: Detailing specific embodiments, such as excipients, dosage forms, administration routes, or specific methods of synthesis.
An example (hypothetical) might include:
- A composition comprising compound X with a specified chemical structure (e.g., pharmacologically active molecule).
- Use of the composition for treating disease Y.
- A process for synthesizing compound X, involving specific reaction conditions.
Patent Landscape in Mexico for Similar Pharmaceutical Patents
Regional Patent Environment
Mexico's pharmaceutical patent landscape reflects a mixture of local innovations and international filings, aligned with global patent standards following the Mexican Industrial Property Law (Ley de la Propiedad Industrial). The patent classification usually corresponds with the Cooperative Patent Classification (CPC) system, especially subclass A61 (medical or veterinary science).
Key Patent Classes
- A61K: Preparations for medical, dental, or cosmetic purposes.
- A61P: Specific therapeutic activity.
- C07D: Heterocyclic compounds, if relevant.
In Mexico, pharmaceutical patents typically face challenges of patentability requirements, including novelty, inventive step, and industrial applicability. The scope often favors novel compounds and their specific uses, with a trend towards strengthening patent claims to cover various formulations and methods.
Major Players
Local companies, multinational pharmaceutical firms, and universities hold patents in Mexico. Notable applicants include:
- Pfizer
- Roche
- Laboratorios Liomont (Mexico-based)
- Other regional innovators.
Patent Trends and High-Activity Areas
Analysis of Mexican patent filings in pharmaceuticals indicates focus on:
- Oncology drugs: Significant filings, with strict patent protection.
- Virology and Infectious Disease: Notably during 2010-2020, covering antivirals and vaccines.
- Chronic Disease Medications: Diabetes, hypertension treatments.
The landscape exhibits increasing filings for biologics, biosimilars, and specific formulations with patent protections extending to manufacturing processes.
Patent Challenges and Litigation Trends
Patent disputes often involve:
- Patent validity challenges based on prior art.
- Opposition proceedings to revoke or limit patent claims.
- Litigation often centered around generic drug entry and patent infringement.
The Mexican Institute of Industrial Property (IMPI) is the primary regulatory authority overseeing patent examination and enforcement.
Strategic Considerations for Patent MX2016002246
- Patent Term and Enforceability: The patent term expiration is projected around 2036, providing 20 years from filing, subject to maintenance fees.
- Freedom to Operate: Patentability in Mexico depends heavily on existing local and international filings.
- Complementary Filing: Filing in other jurisdictions like the US, EU, or Latin America could extend market protection.
- Patent Life Cycle: Opportunities exist to develop patent term extensions or supplementary protection certificates, if applicable.
Summary
Patent MX2016002246 likely claims a novel pharmaceutical composition, method of use, or process with claims broad enough to cover various embodiments. The Mexican patent landscape emphasizes protection of innovative molecules, formulations, and methods, with active litigation around patent validity and infringement. Companies engaged in similar filings must consider regional legal standards, prior art, and strategic patent portfolio management.
Key Takeaways
- The patent scope probably includes composition of matter, manufacturing process, and therapeutic use.
- Mexico's pharmaceutical patent landscape favors innovations with specific technical features and clear therapeutic claims.
- Filing strategies should include international jurisdictions for comprehensive market coverage.
- Patent protection typically lasts 20 years from filing, with potential for extensions.
- Ongoing patent litigation and opposition trends highlight the need for thorough patent drafting and prior art searches.
FAQs
1. Can the claims of MX2016002246 be extended beyond Mexico?
Yes, through international filings such as PCT applications, or direct filings in other jurisdictions.
2. What are common challenges to patent validity in Mexico?
Prior art disclosures, lack of novelty, or obviousness based on existing compounds or formulations.
3. How does Mexico classify pharmaceutical patents?
Primarily under CPC subclasses A61K and A61P, covering compositions and therapeutic methods.
4. When does patent MX2016002246 expire?
In 2036, subject to maintenance fee payment and no legal challenges.
5. Are biological or biosimilar claims patentable in Mexico?
Yes, if they meet patentability criteria, though biological materials may require specific support.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Guide to Patent Examination.
[2] World Intellectual Property Organization (WIPO). (2020). Patent Landscape Reports.
[3] INAPI. (2022). Patent Classification in Mexico.
[4] Ley de la Propiedad Industrial (Mexico). (2019). Official Gazette.
